Ivacaftor, ≥98%

Catalog No. 564586

General Information

Synonyms	VX 770, Kalydeco
CAS No.	873054-44-5
M.F.	C₂₄H₂₈N₂O₃
M.W.	392.49

Technical Data

Appearance	Off-white crystalline powder
Assay	≥98% HPLC
Solubility	DMSO
Storage	-20℃
Description	Ivacaftor is a potentiator approved for patients with the G551D mutation of cystic fibrosis.

Reference

Vachel L, et al. J Cyst Fibros. 2013; pii: S1569-1993(13)00084-2.
Yu H, et al. J Cyst Fibros. 2012;11(3):237-45
Yarlagadda S, et al. Am J Respir Crit Care Med 2012;186(7), 694-696
Flume PA, et al. Chest. 2012;142(3):718-24
Pettit RS, et al. Ann Pharmacother. 2012;46(7-8):1065-75
Eckford PD, et al. J Biol Chem. 2012;287(44):36639-49

Size	Price	Quantity	Favorites
10 mg	USD160
50 mg	USD560

Please inquire for non-standard packs and bulk quantities.

Availability: Ships in 1-3 days

For research use only. Not for human use.

> Certificate of Analysis

> MSDS

	(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject	564586, Ivacaftor, ≥98%, 873054-44-5
*Message
*Code

Ivacaftor, ≥98%

Inquire